NEU-QAP, Bangalore Home
18% GST would be applicable (additional) from 1st Dec 2019 on all registrations and renewals.. GST Number : 29AAGCN1528H1ZE

NEUQAP PTP Programme has been accredited by NABL for compliance as per ISO/IEC 17043:2010

1. View NABL Certificate 2. View NABL Scope Document


About Neu-QAP

Laboratory Medicine is a rapidly growing professional field having many implications on health care. Laboratories come up by the crop, without understanding the impact they will have on health care. There is nothing wrong in laboratories coming on every street as long as there is a commitment to maintain the quality of the results to a minimum standard. Defining this minimum standard has become very subjective and each lab professional defines quality practice in his or her own way, which may be correct or wrong depending on the science behind it. Proficiency testing (PT) is a vital component of Quality Control where the laboratory’s performance is compared against a peer group. At Neu-QAP, our aim is to have a large peer group of laboratories, not only across India, but on a global scale. The modules for PT in the areas of routine haematology, clinical chemistry, serology, histopathology and basic microbiology are already existing as we were the nodal centre for another similar programme. The programmes for other high-end tests including those related to immunohistochemistry, genetics, molecular biology, mass spectrometry and genomics will be developed and introduced in a phased manner. Our priority is to work towards accreditation of the programme as per ISO17043 standard.


To be among the top three providers of PT services globally with the widest menu.

Program Policies

Neu-QAP is the proficiency testing program of Neuberg Anand Academy of Laboratory Medicine, an independent organisation associated with Neuberg Anand Reference Laboratories. The programme will provide cost effective External Quality Assessment to member laboratories. Laboratories can become members by registering to the program, following scrutiny of application by the Quality Manager of NAALM.

Criteria for approval of laboratories would be based on the following:

Authorised signatory should be a medical graduate with qualification approved by the Medical Council of India. The laboratory should have a well-defined internal quality control programme. This is a necessity as day to day variations are best identified by internal quality control. If the laboratory is not NABL accredited, it should provide a proof of running daily quality control in the form of LJ charts or cumulative SD and CV for two months where applicable. If the laboratory does not have record of internal quality control, measures should be taken to record the same in the form of LJ charts. This will help the laboratory to develop a system of records which in turn will help in preparing for the process of accreditation. NABL accredited laboratories are required to provide accreditation details.

Where relevant, the programme will use pooled sera as quality control material to begin with and change over to lyophilized material at a later date. All material (sera) being dispatched to member laboratories should be considered as potentially infectious and handled according. The quality assessment program for histopathology shall focus on two aspects- PART A: on pre-analytical aspects beginning from tissue processing, sectioning to staining. PART B – on analytical aspects (interpretation of slides).

PART A - Tissue samples that are fixed in buffered neutral formalin shall be distributed to all member laboratories. The labs are expected to process the tissue and prepare stained slides which shall then be returned to the nodal centre for evaluation. Parameters like thickness of section, artefacts and staining quality shall be scored and results shall be returned to the lab.
PART B – Identical H&E stained sections from a single block shall be distributed to all member labs along with pertinent history. The labs are expected to return their interpretations and diagnoses in clear terms, in the response sheet that shall be provided. Classification where ever applicable shall follow current and internationally acceptable guidelines. The results shall be compared with the consensus diagnosis and report made.